Correlation Between Altamira Therapeutics and Oncorus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Altamira Therapeutics and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altamira Therapeutics and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altamira Therapeutics and Oncorus, you can compare the effects of market volatilities on Altamira Therapeutics and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altamira Therapeutics with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altamira Therapeutics and Oncorus.

Diversification Opportunities for Altamira Therapeutics and Oncorus

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Altamira and Oncorus is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Altamira Therapeutics and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Altamira Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altamira Therapeutics are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Altamira Therapeutics i.e., Altamira Therapeutics and Oncorus go up and down completely randomly.

Pair Corralation between Altamira Therapeutics and Oncorus

If you would invest  4.35  in Oncorus on August 24, 2024 and sell it today you would earn a total of  0.00  from holding Oncorus or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy4.35%
ValuesDaily Returns

Altamira Therapeutics  vs.  Oncorus

 Performance 
       Timeline  
Altamira Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Oncorus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Altamira Therapeutics and Oncorus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Altamira Therapeutics and Oncorus

The main advantage of trading using opposite Altamira Therapeutics and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altamira Therapeutics position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.
The idea behind Altamira Therapeutics and Oncorus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated